In layman’s terms what Dr. Barret wanted to find out is if Vizilite, VELscope or Identafi saved lives through improving early detection by providers. Nobody actually knows how many adults these products could help, but it is estimated that it is probably well less than 10% of those who develop oral cancer. The increase is not significant enough to warrant a recommendation for use in addition to medically accepted cancer screening methods. I’m not saying that these products are bad or provide no value. They just haven’t proven useful enough to warrant a recommendation. At least not yet. As I stated above, most diseases including cancer have the best outcomes when caught and treated early. Early treatment saves on reconstructive dentistry costs in the long run.